Or, our tax dollars at work! Last week, the FDA approved a new drug for treatment-resistant depression (TRD). The nasal spray version of the drug ketamine, called Spravato (esketamine), is a newly-approved, fast-acting drug, available only with a doctor’s prescription, that could help millions. Did you know that a wide range of nonhuman animal research … Continue reading The animal research behind the new nasal spray depression treatment
Month: March 2019
New advances in optogenetics a key step towards treatment of neurological disorders
A technique neuroscientists use to view neurons in the brain and to turn them on and off with light, called optogenetics, is a promising strategy that could eventually treat a wide range of disorders, from chronic pain to conditions such as epilepsy and Parkinson’s disease. However, scientists using this technique have faced a major hurdle: … Continue reading New advances in optogenetics a key step towards treatment of neurological disorders
Research Roundup: A radical Parkinson’s treatment fails in humans; studying singing in mice gives insight into other mammalian conversations and more!
Welcome to this week’s Research Roundup. These Friday posts aim to inform our readers about the many stories that relate to animal research each week. Do you have an animal research story we should include in next week’s Research Roundup? You can send it to us via our Facebook page or through the contact form … Continue reading Research Roundup: A radical Parkinson’s treatment fails in humans; studying singing in mice gives insight into other mammalian conversations and more!
Speaking of Research 